COMPLIANCE & TRANSPARENCY EXCELLENCE IN LIFE SCIENCES

Register Now
Event info

Amsterdam, The Netherlands

26th - 27th, September

Compliance Industry

Conference Summary

EuroEvents is pleased to invite you to the inaugural edition of the Compliance and Transparency Conference for Life sciences, which will be held on 26th and 27th of September 2019 in Amsterdam, The Netherlands.

As a heavy regulated industry, the companies are constantly facing changing governing requirements. The industry players make great efforts to better design and implement, assess as well as improve programs that would drive compliance into the Corporate DNA. Putting in place a holistic compliance program requires building state-of-the-art programs and practices that would take into account all aspects of industry codes and regulatory requirements.

The new technologies promise to offer imminent value for the industry, but at the same time pose the challenge not only of adoption but also adaptation of the existing programs and practices. The general shift towards these technologies is conditional and depends on the robust evidence and understanding of the benefits that would derive from their acceptance and implementation. Nonetheless, industry leaders and early adopters have been testing and have already put in place a range of solutions in their everyday operations.

Therefore, our Conference will give recognition to the best practices and will offer a platform for open discussion and exchange of ideas on how to overcome the present-day challenges that compliance professionals in the life sciences industry are facing.

Register today to benefit from the learning, benchmarking and networking opportunities and discover ways to accept and implement the best practices tailored to the specific needs of your company.

Join us in the very new home of the European Medicines Agency and become a part of a remarkable event!

 

Speakers and experts

Hear from the leading professionals and experts and learn how they are coping with the challenges in the industry

Detlef Geiges

Company:
Astra Zeneca

View more

Position:
Senior Director Compliance Assurance, Global Methodology & Europe & Russia/Eurasia Lead

Company:
Astra Zeneca

Country:
Germany

Liesbeth Bergmans

Company:
Teva Pharmaceuticals

View more

Position:
General Counsel EU Commercial

Company:
Teva Pharmaceuticals

Paul Melling

Company:
Baker McKenzie

View more

Position:
Founding Partner

Company:
Baker McKenzie

Gabor Sulyok

Company:
Novartis

View more

Position:
Head of Compliance

Company:
Novartis

Albert van Maaren

Company:
Merck KGaA

View more

Position:
ComplianceOfficer North West Europe

Company:
Merck KGaA

Carlo Geninazza

Company:
CAWECO GmbH

View more

Position:
Senior Manager

Company:
CAWECO GmbH

Daniel Schafaghi

Company:
Boehringer- Ingelheim

View more

Position:
Head of Global Compliance Program and Regions Management

Company:
Boehringer- Ingelheim

Country:
Germany

Joanne Skedelsky

Company:
Novartis Pharmaceuticals

View more

Position:
Head Integrity & Compliance UK and Ireland and Country Head Compliance

Company:
Novartis Pharmaceuticals

Vicky N. Kriketou

Company:
KG Law Firm

View more

Position:
Counsel

Company:
KG Law Firm

Natacha Udo-Beauvisage

Company:
Servier

View more

Position:
Global Data Protection Officer

Company:
Servier

Steffen Esche

Company:
PwC

View more

Position:
Senior Manager

Company:
PwC

Tetiana Isaieva

Company:
Roche

View more

Position:
, Head of Compliance EEMEA and Indian Subcontinent

Company:
Roche

Erik Vollebregt

Company:
Axon Lawyers

View more

Position:
Partner

Company:
Axon Lawyers

Aleksej Daineko

Company:
LEO Pharma

View more

Position:
Head of Global Compliance & Risk Business Partnering

Company:
LEO Pharma

An Vijverman

Company:
Dewallens & Partners

View more

Position:
Partner

Company:
Dewallens & Partners

Agenda

Agenda Learn the latest trends in the industry

08:30 - 09:00
Speaker:
Register
Registration & Morning Refreshments

08:30 – Registration & Morning Refreshments 

09:00 – Opening remarks from the Chairman

09:00 - 10:30
Speaker: Albert van Maaren, Gabor Sulyok
Register
Session I: Effective transparency programs as competitive advantage

09:00 –  09:30 Overview of the global landscape 

 

09:30  –  10:00 Transparency and Disclosure of Payments with HCPs in the EU and APAC region

  • First steps in Transparency reporting
  • Disclosure in the EU and the APAC region
  • Pharma Transparency Operations
  • Disclosure Developments

Albert van Maaren, Compliance Officer North West Europe, Merck KGaA

 

10:00  –  10:30 Transparency in Disclosure of Payments and other Transfers of Values – considerations, challenges and best practices

  • Global transparency snapshot
  • EFPIA – new Code of Practice
  • Key considerations in practice (roles and responsibilities, controls and monitoring, etc.)
  • Key challenges (data privacy, outsourcing, etc.)

Gabor Sulyok, Head of Compliance, Novartis

 

10:30 – 11:00 Networking Break

11:00 - 12:30
Speaker: Aleksej Daineko, Joanne Skedelsky, Tetiana Isaieva, Aleksej Daineko
Register
Session II: Culture of continuous improvement: Specific aspects of the compliance programs

11:00  –  11:30 Culture of integrity: Balance between value-driven and control-based compliance.

Aleksej Daineko, Head of Global Compliance & Risk Business Partnering, LEO Pharma

 

11:30  –  12:30 Panel Discussion: Compliance culture and values as a competitive advantage

  • The role of the board in building compliance culture
  • Challenges of incorporating culture and corporate values in the DNA of the Company
  • How to deal with cultural differences across world?

Joanne Skedelsky, Head Integrity & Compliance UK and Ireland and Country Head Compliance, Novartis Pharmaceuticals

Tetiana Isaieva, Head of Compliance EEMEA and Indian Subcontinent, Roche

 Aleksej Daineko, Head of Global Compliance & Risk Business Partnering, LEO Pharma

 

12:30 – 14:00 Lunch Break

14:00 - 15:30
Speaker: Daniel Schafaghi, Detlef Geiges, Carlo Geninazza
Register
Session III: From reactive to strategic approach: Building a holistic compliance program

14:00  –  14:30 Holistic Third Party Risk Management

  • Challenges
  • Opportunities
  • Conclusion & Outlook

Daniel Schafaghi, Head of Global Compliance Program and Regions Management, Boehringer- Ingelheim

 

14:30  –  15:00  The (D)Art of Assurance

  • Global vs. regional vs. local Monitoring
  • Depth of Assurance
  • Use of Data Analytics
  • Adaptive, risk-based Monitoring
  • Learning from Darts

Detlef Geiges, Senior Director Compliance Assurance | Global Methodology & Europe & Russia/Eurasia Lead, Astra Zeneca

 

15:00  –  15:30  Integrity on push of the button

  • Do you know who you are doing business with?
  • Bribery allegations, corruption or money laundering charges, possible breaches of trade sanctions and accidental violation of measures against terrorism financing
  • Integrated solution for an efficient screening

Carlo Geninazza, Senior Manager, CAWECO

 

15:30 – 16:00 Networking Break

16:00 - 17:30
Speaker: Paul Melling, Tetiana Isaieva
Register
Session IV: Compliance programs in High risk areas

16:00 – 16:30  Effective Third Party Risk Management in High Risk Markets – Best Practice

  • Effective third party risk management and use of corporate intelligence suppliers
  • Risk management in state procurement
  • AML issues

Paul Melling, Founding partner, Baker McKenzie

 

16:30 – 17:00  Life Science Risk Strategies in VUCA world

  • How to build a strong risk culture through effective risk positioning
  • New and rising Risks…or…Opportunities
  • Risk appetite: balancing of value creation and value protection

Tetiana Isaieva, Tetiana Isaieva, Head of Compliance EEMEA and Indian Subcontinent, Roche

17:30
Speaker:
Register
END OF CONFERENCE DAY I

End of Day I

Summary and Conclusions

08:30 - 09:00
Speaker: /
Register
Registration & Morning Refreshments

08:30 – Registration & Morning Refreshments 

09:00 – Opening remarks from the Chairman

09:00 - 10:30
Speaker: Erik Vollebregt, Vicky N. Kriketou
Register
Session V: Implications of Regulations and laws

09:00  –  09:30  Competition landscape: Mergers & acquisitions

  • Broader than competition law
  • M&A processes have an important regulatory dimension that is often overlooked by bigger companies.

Erik Vollebregt, Partner, Axon Lawyers

 

 

09:30  –  10:00 Tech giants and start-ups: new market landscape in life science industry

 

10:00  –  10:30  Life Sciences Litigation and Risk Management: How to win before trial

  • How to predict litigation risk
  • How to act proactively and reduce the risk of a dispute
  • How effective programs contribute to the successful defense of unavoidable lawsuits
  • How to balance between compliance requirements and jurisprudence

Vicky N. Kriketou, Counsel, Litigation, KG Law Firm

 

 

10:30-11:00 Networking Break

11:00 - 12:30
Speaker: Steffen Esche
Register
Session VI: Disruptive innovation: Application and challenges of emerging technologies

11:00  –  11:30 Overcome the challenges of adoption of cutting edge technologies

Steffen Esche, Senior Manager, PwC

 

11:30  –  12:00 AI & Machine Learning for compliance in pharma & biotech companies

 

12:00  –  12:30 Continuous improvement of compliance departments: Selection and training programs with e-tools

 

12:30-14:00 Networking lunch

14:00 - 15:30
Speaker: Natacha Udo-Beauvisage, An Vijverman,
Register
Session VII: Data protection: Regulatory and technological challenges

14:00  –  14:30 Unlock the possibilities of big data and ensuring data protection

  • further use of data
  • scientific research as compatible use
  • patients’ expectations on further use
  • transparency

Natacha Udo-Beauvisage, Global Data Protection Officer, Servier, France

 

14:30 – 15:00 Compliance with EU CTR, MDR and GDPR and how it impacts data transparency 

An Vijverman, Partner, Dewallens & Partners

 

15:00  –  15:30 Dealing with the challenges of patient support programs

 

15:30 – 16:00 Networking Break

16:00 - 17:00
Speaker: Liesbeth Bergmans
Register
Session VIII: Foresight of the industry: New trends and challenges

16:00 – 16:30 Social media as a rising compliance issue Social Media in the Pharma Industry: Challenges and Opportunities

  • Setting the stage
  • Legal framework regarding Social Media Use
  • Do’s and Don’ts

Liesbeth Bergmans, General Counsel EU Commercial, Teva Pharmaceuticals, Netherlands

 

16:30 – 17:00Panel Discussion: Prevention over interventions: Effective ABAC programs

17:00
Speaker:
Register
END OF CONFERENCE

Summary and Recap of the Conference

End of Conference

Download Brochure

By clicking Request brochure button you agree to let your personal information which are part of this form be used by EuroEvents MRI for the needs of everyday's operation as well as be used for the purposes of direct marketing, but only according to the General Data Protection Regulation in the European Union.

Event Venue

Venue informations

Address:

Dijsselhofplantsoen 7, 1077 BJ Amsterdam

Phone Number:

+31 (0)20 570 56 00

Sponsorship

Sponsorship Stand out from the crowd and raise your brand awareness